Literature DB >> 11122858

Surgical management of primary melanoma.

D Costello1, A Powers, J Lynn, C W Cruse, D Reintgen.   

Abstract

A significant proportion of the general population is diagnosed with malignant melanoma each year, and more people die of melanoma now than at any time in the past. Consequently, treatment of melanoma at all stages of development is an important clinical issue. A variety of management options are discussed here, including biopsy techniques and treatment of the primary melanoma. The latter include lymphatic mapping and sentinel lymph node biopsy, hyperthermic isolated limb perfusion, and surgery for stage IV melanoma patients. Procedure-associated benefits and possible complications associated with each modality are also summarized.

Entities:  

Mesh:

Year:  2000        PMID: 11122858     DOI: 10.1007/s11912-000-0023-y

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  39 in total

1.  Surgery as palliative treatment for distant metastases of melanoma.

Authors:  I L Wornom; J W Smith; S J Soong; R McElvein; M M Urist; C M Balch
Journal:  Ann Surg       Date:  1986-08       Impact factor: 12.969

2.  Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial.

Authors:  C P Karakousis; C M Balch; M M Urist; M M Ross; T J Smith; A A Bartolucci
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

3.  Resection margins for melanoma.

Authors:  G W Milton; H M Shaw; W H McCarthy
Journal:  Aust N Z J Surg       Date:  1985-06

4.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

5.  Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.

Authors:  C M Balch; T M Murad; S J Soong; A L Ingalls; P C Richards; W A Maddox
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

6.  The natural history of resectable metastatic melanoma (Stage IVA melanoma).

Authors:  L G Feun; J Gutterman; M A Burgess; E M Hersh; G Mavligit; C M McBride; R S Benjamin; S P Richman; W K Murphy; G P Bodey; B W Brown; C F Mountain; M E Leavens; E J Freireich
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

7.  Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.

Authors:  J J Albertini; C W Cruse; D Rapaport; K Wells; M Ross; R DeConti; C G Berman; K Jared; J Messina; G Lyman; F Glass; N Fenske; D S Reintgen
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

8.  Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I).

Authors:  G W Milton; H M Shaw; G A Farago; W H McCarthy
Journal:  Br J Surg       Date:  1980-08       Impact factor: 6.939

9.  Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.

Authors:  D L Fraker; H R Alexander; M Andrich; S A Rosenberg
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

10.  Mohs micrographic surgery using HMB-45 for a recurrent acral melanoma.

Authors:  R D Griego; J A Zitelli
Journal:  Dermatol Surg       Date:  1998-09       Impact factor: 3.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.